School of Medicine, University of California San Francisco, San Francisco, California, USA.
Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
J Neurointerv Surg. 2023 Oct;15(10):1014-1020. doi: 10.1136/jnis-2022-019259. Epub 2022 Sep 8.
Pulsatile tinnitus (PT) can cause significant detriment to quality of life and may herald a life-threatening condition. Endovascular evaluation is the gold standard for the definitive diagnosis of PT and facilitates treatment. However, no large study has determined the distribution of causes and treatment outcomes of PT evaluated endovascularly.
Consecutive patients evaluated at a multidisciplinary PT clinic from a single academic center were retrospectively reviewed. Patients with a suspected cerebrovascular etiology of PT based on clinical and/or non-invasive imaging, who were evaluated by endovascular techniques (arteriography, venography, manometry, and/or balloon test occlusion), were included in analysis. Baseline clinical features and treatment results by final etiology of PT were compared.
Of 552 patients referred for PT evaluation, 164 patients (29.7%) who underwent endovascular evaluation of PT were included. Mean (±SD) age at first clinical evaluation was 54.3±14.1 years (range 25-89 years); 111 patients (67.7%) were female. PT causes were 75.6% vascular and 24.4% non-vascular. Arteriovenous shunting lesions caused 20.7% of cases, venous etiologies 48.2%, and arterial etiologies 6.7%. Of patients with a shunting lesion treated with endovascular embolization, 96.9% had lasting significant improvement or resolution in PT. Endovascular stenting for venous sinus stenosis gave 84.6% of patients lasting improvement or resolution in PT. Arterial and non-vascular PT had fewer patients treated endovascularly and less improvement in PT symptoms.
PT with a suspected vascular cause is most often attributable to venous etiologies. PT caused by arteriovenous shunting or venous sinus stenosis may be effectively treated endovascularly.
脉动性耳鸣(PT)可显著降低生活质量,可能预示着危及生命的疾病。血管内评估是 PT 明确诊断的金标准,并有助于治疗。然而,尚无大型研究确定血管内评估的 PT 病因分布和治疗结果。
回顾性分析了单家学术中心多学科 PT 诊所连续评估的患者。基于临床和/或非侵入性影像学检查,怀疑 PT 有血管性病因的患者,采用血管内技术(血管造影、静脉造影、测压和/或球囊试验闭塞)进行评估,将这些患者纳入分析。比较了 PT 最终病因的基线临床特征和治疗结果。
在 552 例转诊评估 PT 的患者中,有 164 例(29.7%)接受了 PT 的血管内评估。首次临床评估时的平均(±SD)年龄为 54.3±14.1 岁(范围 25-89 岁);111 例(67.7%)为女性。PT 的病因 75.6%为血管性,24.4%为非血管性。动静脉分流病变引起的病例占 20.7%,静脉性病因占 48.2%,动脉性病因占 6.7%。在接受血管内栓塞治疗的分流病变患者中,96.9%的患者 PT 症状有持续显著改善或缓解。静脉窦狭窄的血管内支架治疗使 84.6%的患者 PT 症状持续改善或缓解。动脉性和非血管性 PT 患者接受血管内治疗的人数较少,PT 症状改善较少。
疑似血管性病因的 PT 最常归因于静脉性病因。动静脉分流或静脉窦狭窄引起的 PT 可能通过血管内治疗有效治疗。